ArticleJournal of bone oncology2019

Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model.

Tiina E Kähkönen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.